Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript
Chimerix, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.23.
Chimerix Inc (CMRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 8,800,000 | $8,470,000 | +36% | 0.13% |
| 2. | Armistice Capital Steven Boyd | 2,598,000 | $2,500,575 | -10% | 0.03% |
| 3. | Citadel Investment Group Ken Griffin | 2,062,550 | $1,985,205 | -15% | 0% |
| 4. | Vestal Point Capital Ryan Wilder | 1,400,000 | $1,347,500 | 0.14% | |
| 5. | Millennium Management Israel Englander | 1,087,603 | $1,046,818 | -40% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.96 | 17,295 | Director | 100,000 | 2023-11-17 | Filing | |
| $0.92 | 2,705 | Director | 82,705 | 2023-11-10 | Filing | |
| $0.98 | 20,000 | Director | 80,000 | 2023-09-25 | Filing | |
| $1.14 | 51,700 | Officer | 357,015 | 2023-05-18 | Filing | |
| $1.12 | 75,015 | Officer, Director | 87,000 | 2023-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.04 | 1,744 | 447,021 | 2024-02-14 | Filing | ||
| $1.04 | 1,940 | 110,999 | 2024-02-14 | Filing | ||
| $1.04 | 2,660 | 141,232 | 2024-02-14 | Filing | ||
| $0.99 | 3,610 | Officer | 133,142 | 2023-09-28 | Filing | |
| $1.76 | 3,230 | Officer | 136,752 | 2023-01-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,377,674 | $4,213,511 | 1.24% | |
| 2. | 4,345,579 | $4,182,620 | 0% | |
| 3. | 1,179,533 | $1,135,301 | 0% | |
| 4. | 1,046,352 | $1,007,113 | 0% | |
| 5. | 1,031,524 | $992,842 | 0.02% |
News See All
Chimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Chimerix Third Quarter 2023 Earnings Conference Call.
12 Best Penny Stocks to Buy Under $1
Investors are optimistic as we move into the third quarter earnings season.
5 Most Undervalued Penny Stocks To Invest In
Broadcasting and media company Sirius XM Holdings Inc. (NASDAQ:SIRI) ranks 4th in our list of the most undervalued penny stocks to buy according to hedge funds.
5 Best Quality Penny Stocks to Buy
Chimerix, Inc. (NASDAQ:CMRX) is working on treatments for fatal diseases. Chimerix, Inc.
Chimerix, Inc. (NASDAQ:CMRX) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Chimerix Second Quarter 2023 Earnings Conference Call.
5 Best Growth Stocks for the Next 10 Years
In this piece, we will take a look at the five best growth stocks for the next ten years.
10 Best Rated Penny Stocks to Buy According to Analysts
Investing in small companies, penny stocks, micro-cap or even small-cap companies went out of fashion as soon as the financial markets started to take a beating amid interest rate hikes.
Chimerix, Inc. (NASDAQ:CMRX) Q1 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Chimerix First Quarter 2023 Earnings Conference Call.
5 Cheap Growth Stocks to Buy
Ring Energy, Inc. (NYSE:REI) is included in the list due to its sustained revenue growth that has lasted for more than a year. The firm has posted 77% revenue growth between 2019 and 2022.
Billionaire Hedge Funds
